News

Deal Announcements

Entegrion Nets Venture Capital Debt

Tuesday, November 10, 2015 5:45:00 AM PDT | VentureDeal
   Research Triangle Park, North Carolina  --  Medical technology company Entegrion has raised $526,000 in new venture capital debt funding, according to an SEC filing.

Entegrion has developed technologies for the control of hemorrhage, wound management and associated tissue repair conditions.

In addition, Entegrion has created plasma and platelet technologies that help enhance the safety of human blood supply.

The company sells its products to private buyers as well as public agencies.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Entegrion is still seeking $2.47 million in additional debt investment, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1